News

MolecuLight^® Inc.’s first-of-its-kind handheld fluorescence imaging device receives FDA De Novo clearance for US wound care market

August 14, 2018

PRESS RELEASE_

TORONTO, Aug. 14, 2018 /CNW/ – MolecuLight Inc. achieved a major regulatory milestone permitting expansion into the United States market. FDA has granted De Novo clearance for the ground-breaking wound fluorescence imaging device, the...